Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the First Quarter Ended June 30, 2018; Provides Non-Consolidated Earnings Guidance for the Fiscal First Half of 2018 and Fiscal Year Ending March 31, 2019; Provides Dividend Guidance for the Year Ending March 31, 2019
July 31, 2018 at 12:00 am EDT
Share
Yuki Gosei Kogyo Co., Ltd. reported non-consolidated earnings results for the first quarter ended June 30, 2018. For the period, the company reported net sales of JPY 2,237 million against JPY 2,504 million a year ago. Operating loss was JPY 120 million against profit of JPY 44 million a year ago. Ordinary loss was JPY 95 million against profit of JPY 72 million a year ago. Net loss was JPY 79 million against profit of JPY 27 million a year ago. Net loss per share was JPY 3.66 against earnings of JPY 1.26 a year ago.
For the fiscal first half of 2019, the non-consolidated company expects net sales of JPY 5,100 million, operating loss of JPY 100 million, ordinary loss of JPY 90 million and net loss of JPY 80 million or net loss per share of JPY 3.66.
For the year ending March 31, 2019, the non-consolidated company expects net sales of JPY 10,500 million, operating income of JPY 150 million, ordinary income of JPY 130 million and net income of JPY 50 million or net income per share of JPY 2.29.
The company provided dividend guidance for the year ending March 31, 2019. For the period, the company expects dividend of JPY 3.00 per share compared to JPY 6.00 per share paid in the same period ago.
Yuki Gosei Kogyo Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of amino acids, chemicals and pharmaceuticals. The amino acids business is involved in the manufacture and sale of amino acids and vitamin ingredients. The chemical products business in involved in the manufacture and sale of the tire cord adhesive raw materials, agricultural chemical intermediates, silicon compounds and other products. The pharmaceuticals business is involved in the manufacture and sale of the pharmaceutical raw materials and intermediates. The commission of manufacture operation business is involved in the contract for manufacture operations through subsidiaries. The Company is also involved in the manufacture and sale of foods, food additives, feed additives, fragrances, and cosmetics, as well as the sale of the related raw materials and products.
Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the First Quarter Ended June 30, 2018; Provides Non-Consolidated Earnings Guidance for the Fiscal First Half of 2018 and Fiscal Year Ending March 31, 2019; Provides Dividend Guidance for the Year Ending March 31, 2019
YUKI GOSEI KOGYO CO., LTD. 
